Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008

Annals of Surgical Oncology

Volumn 22, Issue 12, 2015, Pages 3836-3845

  Hartmann Johnsen, Olaf Johan ^a,d   Kåresen, Rolf ^b,c   Schlichting, Ellen ^d   Nygård, Jan F ^a,b  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Oslo University Hospital ^*  (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CONSERVING THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CONSERVATIVE TREATMENT; EARLY STAGE BREAST CANCER; FEMALE; FOLLOW UP; GROUPS BY AGE; HAZARD RATIO; HUMAN; LIFE TABLE; MAJOR CLINICAL STUDY; MASTECTOMY; NORWAY; OVERALL SURVIVAL; PROPORTIONAL HAZARDS MODEL; SENSITIVITY ANALYSIS; ADJUVANT RADIOTHERAPY; BREAST NEOPLASMS; CANCER GRADING; CANCER STAGING; CARCINOMA, DUCTAL, BREAST; COMPARATIVE STUDY; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; PARTIAL MASTECTOMY; PATHOLOGY; REGISTER; REOPERATION; SECONDARY; SURVIVAL RATE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NORWAY; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; REGISTRIES; REOPERATION; SURVIVAL RATE;

EID: 84943351611     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4441-3     Document Type: Article

References (21)

1. Blichert-Toft M, Nielsen M, During M, et al. Long-term results of breast conserving surgery vs. mastectomy for early stage invasive breast cancer: 20-year follow-up of the Danish randomized DBCG-82TM protocol. Acta Oncol (Stockholm, Sweden). 2008;47(4):672–81.
2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233–41.
3. Litiere S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13(4):412–9.
4. Simone NL, Dan T, Shih J, et al. Twenty-five year results of the national cancer institute randomized breast conservation trial. Breast Cancer Res Treat. 2012;132(1):197–203.
5. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227–32.
6. Wilkinson JB, Vicini FA, Shah C, et al. Twenty-year outcomes after breast-conserving surgery and definitive radiotherapy for mammographically detected ductal carcinoma in situ. Ann Surg Oncol. 2012;19(12):3785–91.
7. Norwegian breast cancer group (www.nbcg.no).
8. Cancer Registry of Norway (www.kreftregisteret.no) Cancer in Norway 2010.
9. Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer. 2013;119(7):1402–11.
10. Agarwal S, Pappas L, Neumayer L, Kokeny K, Agarwal J. EFfect of breast conservation therapy vs mastectomy on disease-specific survival for early-stage breast cancer. JAMA Surg. 2014.
11. Larsen IK, Smastuen M, Johannesen TB, et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–31.
12. (UICC) UfICC. The TNM classification of Malignant Tumors, 7th edn; 2009.
13. Orsini N. A tool for deterministic and probabilistic sensitivity analysis of epidemiologic studies. Stata J. 2008;8(1):29–48.
14. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst. 2000;92(14):1143–50.
15. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial. Cancer. 2003;98(4):697–702.
16. Hwang ES, Lichtensztajn D, Gomez S, Fowble B, Clarke C. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status.
17. Mac Bride MB, Neal L, Dilaveri CA, et al. Factors associated with surgical decision making in women with early-stage breast cancer: a literature review. J Women’s Health (2002). 2013;22(3):236–42.
18. Albain KS, Green SR, Lichter AS, et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. J Clin Oncol. 1996;14(11):3009–17.
19. Moller P, Hagen AI, Apold J, et al. Genetic epidemiology of BRCA mutations–family history detects less than 50% of the mutation carriers. Eur J Cancer. 2007;43(11):1713–7.
20. Opsahl EM, Westre B, Samset JH, Olafsson S, Michelsen K, Varhaug JE. Breast cancer: diagnosis and treatment in a Alesund hospital. Tidsskrift Norske Laegeforen. 2010;130(7):724–8.
21. Morrow M, Jagsi R, Alderman AK, et al. Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA. 2009;302(14):1551–6.